Sign In to View Organizational & Contract Pricing.
Select a Size
About This Item
Empirical Formula (Hill Notation):
C18H13NNa2O8S2
CAS Number:
Molecular Weight:
481.41
UNSPSC Code:
41116107
NACRES:
NA.24
SMILES string
[Na+].[Na+].[S](=O)(=O)([O-])Oc1ccc(cc1)C(c3ncccc3)c2ccc(cc2)O[S](=O)(=O)[O-]
InChI
1S/C18H15NO8S2.2Na/c20-28(21,22)26-15-8-4-13(5-9-15)18(17-3-1-2-12-19-17)14-6-10-16(11-7-14)27-29(23,24)25;;/h1-12,18H,(H,20,21,22)(H,23,24,25);;/q;2*+1/p-2
InChI key
GOZDTZWAMGHLDY-UHFFFAOYSA-L
grade
pharmaceutical primary standard
API family
sodium picosulfate
manufacturer/tradename
EDQM
application(s)
pharmaceutical (small molecule)
format
neat
storage temp.
2-8°C
General description
This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the issuing Pharmacopoeia.For further information and support please go to the website of the issuing Pharmacopoeia.
Application
Picosulfate for system suitability EP Reference standard, intended for use in laboratory tests only as specifically prescribed in the European Pharmacopoeia.
Packaging
The product is delivered as supplied by the issuing Pharmacopoeia. For the current unit quantity, please visit the EDQM reference substance catalogue.
Other Notes
Sales restrictions may apply.
Storage Class
11 - Combustible Solids
wgk
WGK 3
flash_point_f
Not applicable
flash_point_c
Not applicable
Choose from one of the most recent versions:
Already Own This Product?
Find documentation for the products that you have recently purchased in the Document Library.
G Manes et al.
Colorectal disease : the official journal of the Association of Coloproctology of Great Britain and Ireland, 15(9), 1145-1153 (2013-04-16)
The study compared the efficacy, safety and tolerability of a low-volume picosulphate/magnesium citrate preparation with that of polyethylene glycol plus ascorbic acid (PEG + ASC) in a randomized clinical trial (RCT). A multicentre randomized, single-blinded study was designed. Adult outpatients
Jennifer A Flemming et al.
Gastrointestinal endoscopy, 75(3), 537-544 (2011-12-24)
Picosulfate, magnesium oxide, and citric acid solution is a small-volume agent for colon cleansing before colonoscopy that is extremely well tolerated by patients, safe, and efficacious. Studies of other cleansing agents have suggested that split-dose regimens may further enhance efficacy.
Drug eruption due to sodium picosulfate.
Asuka Ishikawa et al.
European journal of dermatology : EJD, 22(3), 410-411 (2012-03-13)
Douglas K Rex et al.
Gastrointestinal endoscopy, 78(1), 132-141 (2013-04-10)
New bowel cleansers for colonoscopy that lead to improved efficacy, safety, and tolerability are needed. This study evaluated a nonphosphate, dual-action, low-volume, orange-flavored preparation containing sodium picosulfate and magnesium citrate (P/MC). Multicenter, assessor-blinded, randomized, noninferiority study. University hospitals, academic medical
Naoki Hosoe et al.
Journal of gastroenterology and hepatology, 27(10), 1617-1622 (2012-06-01)
In Japan, patient acceptance of bowel preparation methods before colonoscopy remains unknown. This study was conducted to evaluate the patient acceptance of sodium phosphate (NaP) tablets and polyethylene glycol solution (PEG) with sodium picosulfate. One hundred patients were randomized into
Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.
Contact Technical Service